August 14, 2022 Comments Off on New patent for Acacia drug BYFAVO Posted in: Patent Added Annual Drug Patent Expirations for BYFAVO Byfavo is a drug marketed by Acacia and is included in one NDA. There are ten patents protecting this drug. This drug has forty-four…
The post New patent for Acacia drug BYFAVO appeared first on DrugPatentWatch…
August 14, 2022 Comments Off on New patent for Novartis drug MAYZENT Posted in: Patent Added Annual Drug Patent Expirations for MAYZENT Mayzent is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Novartis drug MAYZENT appeared first on DrugPaten…
